APPLICATION OF NERVE GROWTH FACTOR IN EYE DROPS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM PATHOLOGIES SUCH AS ALZHEIMER'S AND PARKINSON DISEASES Russian patent published in 2011 - IPC A61K38/18 A61P25/00

Abstract RU 2429007 C2

FIELD: medicine.

SUBSTANCE: invention represents application of nerve growth factor (NGF) for obtaining eye composition for introduction on eye surface for treatment and/or prevention of pathologies affecting central nervous system, said eye composition is in form of eye drops and contains from 10 to 500 mcg/ml NGF.

EFFECT: increase of NGF level in all brain tissues, including cerebrospinal fluid, which makes it possible to demonstrate its therapeutic abilities in situ in case of neurodegenerative and ischemic diseases of brain, including, in particular, Alzheimer's disease and Parkinson's disease.

21 cl, 3 tbl

Similar patents RU2429007C2

Title	Year	Author	Number
PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASE	2012	Khess Zibille Khelsher Kristian Beme Andres Menyu Agnes Prade Loran Topen Veronik	RU2618412C2
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT	2003	Tatton Vil'Jam G. Viler Larri A. Dzhil Dehniehl V. Donello Dzhon E.	RU2332218C2
COMPOSITION, CONTAINING MIXED EXTRACT OF MULBERRY AND PORIA COCOS SKIN, INTENDED FOR PREVENTION, RELIEF AND TREATMENT OF NEURODEGENERATIVE DISORDERS	2015	Choi Sang Zin Sohn Mi Won Go Hyo Sang Ryu Ja Young Jeong Jin Seok Choi Song Hyen Kim Eun Jin Cho Young Woong Kim So Young	RU2679654C2
GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG	2021	Arkhipova Svetlana Sergeevna Alatrash Rim Garanina Ekaterina Evgenevna Rizvanov Albert Anatolevich	RU2762855C1
COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES	2005	Frenkel' Dehn Maron Rut Bert Dehvid Uehjner Khovard L.	RU2387453C2
APPLICATION OF K-252A DERIVATIVES TO TREAT DISORDERS OF PERIPHERAL OR CENTRAL NERVOUS SYSTEMS AND EXCESSIVE CYTOKINE OUTPUT	1997	Ehngber Tomas M. Khaun Forrest A. Saporito Majkl S. Ehjmon Lajza D. Miller Mehtt'Ju S. Najt Ehrnest Ml.	RU2183959C2
PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS	2004	Kkhan Firdos Alam Totej Satish Makhadeorao	RU2380410C2
METHODS, PHARMACEUTICAL COMPOSITIONS AND PRODUCTS FOR THERAPEUTIC CELL INTRODUCTION INTO ANIMAL'S CENTRAL NERVOUS SYSTEM	2008	Frej Vtoroj Uill'Jam G. Daniljan Luzina Glajter Kristof Kh.	RU2468818C2
TREATMENT OF NEUROLOGICAL DYSFUNCTION BY USING FRUCTOPYRANOSE AND ERYTHROPOIETIN SULFAMATES	2002	Plata-Salaman Karlos Smit-Svintoski Virdzhinija	RU2317086C2
APPLICATION OF THERAPEUTIC HUMAN ALBUMIN FOR PREPARING DRUG FOR TREATING PATIENTS SUFFERING COGNITIVE DISORDERS	2008	Grifol'S Roura Viktor	RU2414925C2

RU 2 429 007 C2

Authors

Lamb'Jaze Alessandro

Bonini Stefano

Dates

2011-09-20—Published

2006-08-11—Filed